 |
August
9,
2010
|
Recalls
Listed in this Alert (Click Headline to jump to Article):
FDA
posts press releases and other notices of recalls and market
withdrawals from the firms involved as a service to consumers, the
media, and other interested parties. FDA does not endorse either the
product or the company.
South Bend Chocolate
Company Announces Nationwide Recall of Bountiful Blend Chocolates Due
to Undeclared Tree Nuts
Contact:
Mark Tarner,
(574) 233-2577
The
South Bend Chocolate Company, South Bend, Indiana, is recalling 174
1-lb bags of Bountiful Blend, a blend of chocolate covered mixed nuts
and dried fruits, because it contains undeclared cashews, almonds,
pecans, and Brazil nuts. People who have an allergy or severe
sensitivity to cashews, pecans, almonds or Brazil nuts run the risk of
serious or life-threatening allergic reaction if they consume this
product.
Bountiful Blend was sold via internet sales, mail order and may have
been sold nationwide through our distributors to retail stores.
The Bountiful Blend product impacted by the recall is sold under The
South Bend Chocolate Company brand name and was produced on or after
March 18, 2010. The product under recall is:
- Bountiful
Blend in 1-lb Bags. Products with labels reading Item #154,UPC
#644823001549 are subject to this recall.
No illnesses have been reported to date.
This recall was initiated after it was discovered that Bountiful Blend
containing cashews, pecans, almonds or Brazil nuts were not listed on
the product’s labeling. Subsequent investigation indicates the problem
was caused by the printing of ingredient statements and was cut off
before the listing of nuts printed.
Consumers who have purchased 1-lb bags of Bountiful Blend are urged to
contact The South Bend Chocolate Company at (574) 233-2577 Monday
through Friday from 8 a.m. to 5 p.m. Eastern time or return them to the
place of purchase for a full refund.
FDA
posts press releases and other notices of recalls and market
withdrawals from the firms involved as a service to consumers, the
media, and other interested parties. FDA does not endorse either the
product or the company.
EZVille, Ltd. Issues a
Voluntary Nationwide Recall of Solo Slim® Found to Contain an
Undeclared Drug Ingredient
Contact:
Eric Budzinski,
(866) 673-8483
EZVille, Ltd. has been informed by the Food and Drug Administration
(FDA) that FDA lab analysis of Solo Slim® distributed by the
company was found to contain an undeclared drug ingredient. Solo
Slim® was found to contain Didesmethyl Sibutramine. Sibutramine is
an FDA-approved drug used as an appetite suppressant for weight loss.
The FDA has not approved Solo Slim®, therefore the safety and
effectiveness of the product is unknown.
FDA advises that Solo Slim® poses a threat to consumers because
Sibutramine is known to substantially increase blood pressure and/or
pulse rate in some patients and may present a significant risk for
patients with a history of coronary artery disease, congestive heart
failure, arrhythmias or stroke.
EZVille, Ltd. has decided to recall Solo Slim® and Solo Slim®
Extra Strength products, both marketed as dietary supplements for
weight loss. Solo Slim® is packaged in white plastic bottles with
blue screw-on cap containing 30 capsules per bottle and bears UPC 8
35470 00206 9. Solo Slim® Extra Strength is packaged in white
plastic bottles with blue screw-on cap containing 30 capsules per
bottle and bears UPC 8 35470 00220 5. All lots of these products with
expiration dates including and prior to August 2013 currently available
on the market are being recalled. The products were sold to
distributors and retail stores nationwide and via internet sales.
No illnesses or injuries have been reported to the company to date in
connection with these products.
EZVille, Ltd. is taking this voluntary action because of the concern
for the health and safety of consumers. The company has discontinued
distribution of these affected products. It sincerely regrets any
inconvenience to our customers.
Consumers should not consume Solo Slim® and Solo Slim® Extra
Strength, and should return them immediately to the place of purchase
for a full refund. Consumers should contact their physician if they
have experienced any problems that may be related to taking these
products. Consumers with questions should contact Eric Budzinski at
(866) 673-8483, Monday through Friday, 9:00 am to 5:30 pm, EDT.
Any adverse reactions experienced with the use of these products may be
reported to the FDA's MedWatch Safety Information and Adverse Event
Reporting Program online
, by phone (800) 332-1088 [(800) FDA-1088], or by returning the
postage-paid FDA form 3500 [which may be downloaded from the MedWatch
"Download Forms" page], by mail [to address on the pre-addressed form]
or fax [(800)FDA-0178].
This recall action is being conducted with the knowledge of the U.S.
Food and Drug Administration.
Product Recall is a
publication of the California Grocers Association, 1415 L Street, Suite
450, Sacramento, CA 95814. For
more recall information, log on to www.cagrocers.com,
or
email/call
Lesley Scofield,
CGA,
at
(916)
448-3545.
To unsubscribe to Product Recall, contact Lesley Scofield.
|
|